Diluted HEPS declined to 39.8cps (-3.4% y-y).
Turnover growth +12.9% y-y driven by strong performance in Hospitals and complimentary services (+13.1% y-y) as well as International Diagnostics (+15.5%)
Expenses grew by +12.3% y-y, with expenses to sales decreasing by 40bps to 90.9%.
OPM reduced by 10bps to 9.4%.
Dividend of 17cps (1H22:15cps).
Gross debt increased from R11.6bn to R13.8bn.
The business secured additional network deals with the Government Employee Medical Scheme (GEMs) and Medscheme which came into effect January 2023.
During the period, LHC announced the acquisition of the non-clinical imaging operations TheraMed Nuclear as well as announcing the acquisition of assets of 51 renal dialysis clinics in southern Africa from Fresenius Medical Care.
